← Back
business Updated 6–7 Oct 2026

Pharma companies’ profits rise 28% in FY26

HarZaviya summary · from 4 outlets

Most outlets reported the 28% year-on-year increase in profits of Pakistan’s listed pharmaceutical companies, citing the rise to Rs42.2 billion in FY26. Abb Takk News added context, noting that the increase was supported by higher medicine prices and reduced financing costs, while ARY News provided a more concise version without additional details.

Summary generated by HarZaviya from the headlines and excerpts of the 4 outlets below. Each outlet's own headline is listed under it.

Same story from 4 outlets

Each outlet's own headline, most recent first — read any at its source.

  1. Price-led growth lifts Pakistan pharma profits 28% to Rs42.2 billion in FY26

    Sales increase 10% to Rs377.9 billion as gross margins hit an all-time high of 42.8%; finance costs fall 42% to Rs3.6 billion while sector market cap rises just 2.3%

  2. Business Recorder 84% identical

    Pharma listed cos: FY26 profits surge 28pc to Rs42.2bn YoY

    KARACHI: Profitability of Pakistan’s listed pharmaceutical sector increased 28 percent year-on-year (YoY) to Rs42.2 billion in FY26, mainly supported by price-led growth and lower finance costs, according to a Research report issued. However, sector earnings declined 2 percent YoY and 26 percent quarter-on-quarter (QoQ) in 4QFY26, primarily due to the loss posted by The Searle Company Limited (...

  3. Abb Takk News 85% identical

    Listed pharma firms’ FY26 profits rise 28% to Rs42.2bn

    KARACHI: Profits at Pakistan’s listed pharmaceutical companies climbed 28% year-on-year to Rs42.2 billion in FY26, supported mainly by higher medicine prices and reduced financing costs, according to a sector report. Combined net sales grew 10% to Rs377.9bn, up from Rs342.6bn in FY25. Fourth-quarter sales rose 3% year-on-year to Rs88.9bn. The...

  4. ARY News (English) 83% identical

    Pharma companies’ profits jump 28% in FY26

    KARACHI: The profitability of Pakistan’s listed pharmaceutical companies increased 28% year-on-year (YoY) to Rs42.2 billion in FY26

4 articles from 4 outlets, 6 Oct–7 Oct 2026. Headlines and links belong to their outlets — HarZaviya links out and never copies article text. What does % identical mean?